Literature DB >> 3319304

Brain-reactive autoantibody levels in the sera of ageing autoimmune mice.

S A Hoffman1, D N Arbogast, P M Ford, D W Shucard, R J Harbeck.   

Abstract

Brain-reactive autoantibodies are thought to play an important role in mediating central nervous system (CNS) disorders in systemic lupus erythematosus (SLE). In this paper the developmental occurrence of these antibodies in the sera of autoimmune mice, i.e. NZB, NZB/W, MRL/l and BXSB mice were examined. All murine strains tested, whether autoimmune or not, showed some degree of serum reactivity toward brain antigens. Autoimmune mice, however, displayed higher levels of serum brain-reactive antibodies, and at earlier ages, than non-autoimmune mice. Immunofluorescence assays against brain sections and adsorption assays, with both neural and non-neural tissue, indicated a heterogeneity in the specificity of the populations of brain-reactive antibodies present. These studies provide an important step in characterizing the appearance and diversity of brain-reactive autoantibodies, with the goal of better understanding their significance and potential role in mediating CNS dysfunction in SLE.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3319304      PMCID: PMC1542230     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  32 in total

1.  Antibodies to dissociated cerebellar cells in New Zealand mice as demonstrated by immunofluorescence.

Authors:  S A Hoffman; A A Hoffman; D W Shucard; R J Harbeck
Journal:  Brain Res       Date:  1978-03-10       Impact factor: 3.252

2.  Natural cytotoxic autoantibody against thymocytes in NZB mice.

Authors:  T Shirai; R C Mellors
Journal:  Clin Exp Immunol       Date:  1972-09       Impact factor: 4.330

3.  Antibodies against neurons in a patient with systemic lupus erythematosus, cerebral palsy, and epilepsy.

Authors:  H Diederichsen; I C Pyndt
Journal:  Brain       Date:  1970       Impact factor: 13.501

4.  The neurological manifestations of systemic lupus erythematosus.

Authors:  R T Johnson; E P Richardson
Journal:  Medicine (Baltimore)       Date:  1968-07       Impact factor: 1.889

5.  Serologic studies in patients with systemic lupus erythematosus and central nervous system dysfunction.

Authors:  J B Winfield; C M Brunner; D Koffler
Journal:  Arthritis Rheum       Date:  1978-04

6.  A naturally occurring antibody in New Zealand mice cytotoxic to dissociated cerebellar cells.

Authors:  R J Harbeck; A A Hoffman; S A Hoffman; D W Shucard; R I Carr
Journal:  Clin Exp Immunol       Date:  1978-02       Impact factor: 4.330

7.  Brain-reactive lymphocytotoxic antibodies in the serum of patients with systemic lupus erythematosus.

Authors:  H G Bluestein; N J Zvaifler
Journal:  J Clin Invest       Date:  1976-02       Impact factor: 14.808

Review 8.  Neuropsychiatric manifestations of systemic lupus erythematosus: diagnosis, clinical spectrum, and relationship to other features of the disease.

Authors:  E J Feinglass; F C Arnett; C A Dorsch; T M Zizic; M B Stevens
Journal:  Medicine (Baltimore)       Date:  1976-07       Impact factor: 1.889

9.  Neurocytotoxic antibodies in serum of patients with systemic lupus erythematosus.

Authors:  H G Bluestein
Journal:  Proc Natl Acad Sci U S A       Date:  1978-08       Impact factor: 11.205

10.  Brain reactivity of lymphocytotoxic antibodies in systemic lupus erythematosus with and without cerebral involvement.

Authors:  B Bresnihan; M Oliver; R Grigor; G R Hughes
Journal:  Clin Exp Immunol       Date:  1977-12       Impact factor: 4.330

View more
  5 in total

Review 1.  Neuroimmunopathology in a murine model of neuropsychiatric lupus.

Authors:  David A Ballok
Journal:  Brain Res Rev       Date:  2006-12-20

2.  Anti-alpha-internexin autoantibody from neuropsychiatric lupus induce cognitive damage via inhibiting axonal elongation and promote neuron apoptosis.

Authors:  Xiao-ye Lu; Xiao-xiang Chen; Li-dong Huang; Chang-qing Zhu; Yue-ying Gu; Shuang Ye
Journal:  PLoS One       Date:  2010-06-15       Impact factor: 3.240

3.  Purine receptor antagonist modulates serology and affective behaviors in lupus-prone mice: evidence of autoimmune-induced pain?

Authors:  David A Ballok; Boris Sakic
Journal:  Brain Behav Immun       Date:  2008-06-14       Impact factor: 7.217

4.  Circulating brain-reactive autoantibodies and behavioral deficits in the MRL model of CNS lupus.

Authors:  S Williams; B Sakic; S A Hoffman
Journal:  J Neuroimmunol       Date:  2009-11-17       Impact factor: 3.478

Review 5.  The MRL/lpr mouse strain as a model for neuropsychiatric systemic lupus erythematosus.

Authors:  Maria Gulinello; Chaim Putterman
Journal:  J Biomed Biotechnol       Date:  2011-02-10
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.